69 decentralized-control-for-large-scale-systems Fellowship positions at Northeastern University
Sort by
Refine Your Search
-
About the Opportunity About Khoury College Khoury College is committed to building a diverse and inclusive community among students, faculty and staff. We strongly encourage applicants from
-
: This area focuses on the design, development and governance of AI systems, as well as the evaluation, monitoring, and auditing of such systems. NLP & IR 3.0: This area covers the study of large language
-
human and natural systems as well as intrinsic variability. The need to translate to variables and scales relevant for stakeholders with appropriate uncertainty quantification requires physics-guided AI
-
expertise to research on hospital-scale cybersecurity simulations and vulnerability mitigation platforms. Lead or participate in experimental studies of medical device and healthcare system security
-
, neoantigens, cytokines, and antibodies; bispecific antibodies; and small-molecule immunomodulators. BioNTech is partnered with several large pharmaceutical companies, including Bristol Myers Squibb, Duality
-
About the Opportunity Khoury College of Computer Sciences is looking for a Distinguished Research Fellow. Responsibilities: The Distinguished Research Fellow will be expected to start-up their own
-
About the Opportunity Program Overview Northeastern University Pharmaceutical Industry Fellowships Program is a two-year experiential program designed to advance lifelong learning and the education
-
Belong”. Apellis is committed to developing transformative therapies for people living with a broad range of debilitating diseases by controlling complement, part of the body’s immune system. Apellis
-
employer around the world. Alnylam is extremely proud to have been recognized as the #1 Large Employer by Boston Globe Top Places to Work in 2023 for the third consecutive year, one of Science Magazine's Top
-
controlling complement, part of the body's immune system. Apellis Pharmaceuticals Medical Affairs supports the company mission by getting the right drug, to the right patient, at the right time. In 2022